1.
Atak F, Aydın GB, Öncel İ, Öz S, Oğuz KK. Rhombencephalitis and longitudinal extensive myelitis associated with dinutuximab use in high-risk neuroblastoma. Turk J Pediatr 2023; 65: 523-530. https://doi.org/10.24953/turkjped.2022.598